Chair in Regenerative Medicine
Queensland University of Technology (QLD, Australia)
“There are many conferences which cover these topics, but there aren’t many conferences, or there are no conferences, which really cover the translational part of 3D printing in medicine.”
Distinguished Professor Dietmar Hutmacher is a biomedical engineer, an educator, an inventor and a creator of new intellectual property opportunities. He directs the Centre for Regenerative Medicine and the ARC Training Centre in Additive Biomanufacturing at Queensland University of Technology, an interdisciplinary team of researchers including engineers, cell biologists, polymer chemists, clinicians and veterinary surgeons. He is an internationally recognized leader in the fields of biomaterials, tissue engineering and regenerative medicine with expertise in commercialization. He has translated a bone tissue engineering concept from the laboratory through to clinical application involving in vitro experiments, preclinical studies and, ultimately, clinical trials. His recent research efforts have resulted in traditional scientific/academic outputs as well as pivotal commercialisation outcomes. His pre-eminent international standing and impact on the field are illustrated by his publication record (more than 300 journal articles, edited 14 books, 70 book chapters and some 500 conference papers) and citation record (more than 34,000 citations, h-index of 84).
Hutmacher currently maintains the position of Editor-in-Chief of Future Science Group publication, Journal of 3D Printing in Medicine.
“The 3DMedLIVE conference will be an excellent platform to demonstrate that 3D printing technology enables more effective patient consultations, increases diagnostic quality, improves surgical planning, acts as an orientation aid during surgery and provides a template for surgical resection. The conference will involve leaders in the field presenting on how today’s 3D printing technology has the potential to be very valuable to clinicians for delivering and performing patient-specific individualised surgery.”